Published:
May 13, 2021
Services:
Chemicals More...
Priorities:
Achieving Sustainability More...
Topics:
Activities:
Other financial
Further Reading
Redefine Meat raises $29 million Series A round for 3D-printed plant-based meat
News Commentary | February 17, 2021
Happiness Capital and Hanaco Ventures co‑led the round, which brings the company's total funding to $35 million. The Series A round will go toward the completion of a pilot production facility and a 2021 commercial launch in Europe, followed by Asia and North America. Lux has had a healthy dose of ... Not part of subscription
Dandelion raises $30 million Series B as momentum for the geothermal heating and cooling system startup continues to grow
News Commentary | February 26, 2021
This marks Breakthrough Energy Ventures' first investment since announcing its $1 billion fund in January. Venture capital funding for geothermal startups has sharply fallen since its peak in 2010, but Dandelion joins Eavor as the second geothermal startup to raise funding in 2021, with the two ... Not part of subscription
G2 Venture closes $500 million fund targeting climate change-mitigating technologies but still lacks deep decarbonization startups
News Commentary | July 08, 2021
Last month, G2V announced the close of a $500 million fund following its inaugural $350 million fund in 2017. Continuing with its original investment thesis, G2V will target companies active in the energy, manufacturing, logistics, transportation, and agriculture industries, with an emphasis on "... Not part of subscription
by Kristin Marshall and Harini Venkataraman
Backed by Harry Sloan and Jeff Sagansky, this merger with Soaring Eagle Acquisition will give Ginkgo a pre-money equity valuation of $15 billion, with an additional $2.5 billion for the combined entity – one of the biggest SPAC deals in recent times. This news comes on the heels of Zymergen's IPO announcement, through which it raised $500 million. While the two have significantly evolved over the years, in Ginkgo's case, the company has further diversified through different spinouts targeting ag biologicals, alternative protein ingredients, and bioremediation. Clients should note that Ginkgo is playing a numbers game – it does not depend on any one project to succeed. Additional funding will only expand its reach and disruption potential.
For the original news article, click here .